GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
No information available. |
Summary of Clinical Use ![]() |
Xisomab 3G3 (AB023) was advanced to clinical trial as an antithrombotic agent. |
Clinical Trials | |||||
Clinical Trial ID | Title | Type | Source | Comment | References |
NCT03097341 | Safety and Tolerability Study of Xisomab 3G3 in Healthy Adult Subjects | Phase 1 Interventional | Aronora, Inc. | ||
NCT03612856 | Safety and Efficacy Study of AB023 (Xisomab 3G3) in End Stage Renal Disease Patients on Chronic Hemodialysis | Phase 2 Interventional | Aronora, Inc. | 1 |